FI853639L - Substituerade kinazolindioner. - Google Patents

Substituerade kinazolindioner.

Info

Publication number
FI853639L
FI853639L FI853639A FI853639A FI853639L FI 853639 L FI853639 L FI 853639L FI 853639 A FI853639 A FI 853639A FI 853639 A FI853639 A FI 853639A FI 853639 L FI853639 L FI 853639L
Authority
FI
Finland
Prior art keywords
kinazolindioner
substitutes
kinazolindioner substitutes
Prior art date
Application number
FI853639A
Other languages
English (en)
Finnish (fi)
Other versions
FI853639A0 (fi
Inventor
Stanley C Bell
Donald W Combs
Robert Falotico
Alfonso J Tobia
Victor T Bandurco
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of FI853639A0 publication Critical patent/FI853639A0/fi
Publication of FI853639L publication Critical patent/FI853639L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/44Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/59Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C205/60Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms in ortho-position to the carboxyl group, e.g. nitro-salicylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
FI853639A 1984-09-24 1985-09-23 Substituerade kinazolindioner. FI853639L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/653,620 US4639518A (en) 1984-09-24 1984-09-24 Substituted quinazolinediones

Publications (2)

Publication Number Publication Date
FI853639A0 FI853639A0 (fi) 1985-09-23
FI853639L true FI853639L (fi) 1986-03-25

Family

ID=24621636

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853639A FI853639L (fi) 1984-09-24 1985-09-23 Substituerade kinazolindioner.

Country Status (17)

Country Link
US (1) US4639518A (ru)
EP (1) EP0176333A3 (ru)
KR (1) KR900001181B1 (ru)
AU (1) AU578491B2 (ru)
DK (1) DK431185A (ru)
ES (2) ES8701737A1 (ru)
FI (1) FI853639L (ru)
GR (1) GR852324B (ru)
HU (1) HU196188B (ru)
IL (1) IL76467A0 (ru)
NO (1) NO853730L (ru)
NZ (1) NZ213474A (ru)
PL (1) PL255499A1 (ru)
PT (1) PT81182B (ru)
SU (1) SU1409129A3 (ru)
ZA (1) ZA857302B (ru)
ZW (1) ZW16785A1 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711883A (en) * 1985-09-30 1987-12-08 Ortho Pharmaceutical Corporation Substituted 3-(4-phenyl-1-piperazinyl)alkylquinazolin-2,4-(1H,3H) diones, methods of preparation, compositions and method of use
US4703120A (en) * 1986-04-28 1987-10-27 Ortho Pharmaceutical Corporation Furo(3,4-d)pyrimidine-2,4-dione derivatives and intermediates thereof
DE3929589A1 (de) * 1989-09-06 1991-03-07 Basf Ag Verfahren zur herstellung von 3,7-dialkylxanthinen
EP0594758A1 (en) * 1991-07-15 1994-05-04 Merck & Co. Inc. Novel process for aromatic bromination
DE4339209A1 (de) * 1993-11-17 1995-05-18 Hoechst Ag Verfahren zur Herstellung von substituierten Chinazolin-2,4-dionen
DE4429978A1 (de) * 1994-08-24 1996-02-29 Bayer Ag Verfahren zur Herstellung von Chinazolin-2,4-dionen
EP0742213A1 (de) * 1995-05-10 1996-11-13 Hoechst Aktiengesellschaft Verfahren zur Herstellung von substituierten 3-Arylchinazolin-2,4-dionen
DE19532052C2 (de) * 1995-08-31 1998-11-19 Clariant Gmbh Verfahren zur Herstellung von Chinazolinderivaten
CA2245586A1 (en) * 1996-02-06 1997-08-14 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
EP3180318B1 (en) * 2014-08-11 2019-02-20 Hydra Biosciences, Inc. Quinazoline-2,4(1h,3h)-dione derivatives as trcp5 modulators for the treatment of neuropsychiatric disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202895A (en) * 1971-06-04 1980-05-13 Sumitomo Chemical Company, Limited 1-Polyhaloalkyl-2(1H)-quinazolinone derivatives
US4146717A (en) * 1972-04-07 1979-03-27 Sumitomo Chemical Company, Limited Nitroquinazolinone compounds having antiviral properties
US3879393A (en) * 1973-06-18 1975-04-22 Miles Lab Derivatives of 1,3-disubstituted 2,4(1h,3h)-quinazolinediones
US3983120A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3988340A (en) * 1975-01-23 1976-10-26 Bristol-Myers Company 6-Alkoxymethyl-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones and 7-alkoxymethyl-6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]quinazolin-2-ones
ATE8626T1 (de) * 1980-03-10 1984-08-15 Berri-Balzac Societe Dite: 3-amino-(1h,3h)-2,4-chinazolindionderivate.
US4634769A (en) * 1984-09-25 1987-01-06 Ortho Pharmaceutical Corporation Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts

Also Published As

Publication number Publication date
KR900001181B1 (ko) 1990-02-27
DK431185A (da) 1986-03-25
PT81182B (en) 1987-03-30
HUT40087A (en) 1986-11-28
US4639518A (en) 1987-01-27
FI853639A0 (fi) 1985-09-23
ES553602A0 (es) 1987-12-01
NZ213474A (en) 1988-10-28
HU196188B (en) 1988-10-28
ES547205A0 (es) 1986-12-01
EP0176333A2 (en) 1986-04-02
AU578491B2 (en) 1988-10-27
GR852324B (ru) 1986-01-24
ES8800910A1 (es) 1987-12-01
ZA857302B (en) 1987-05-27
NO853730L (no) 1986-03-25
AU4769885A (en) 1986-04-10
PT81182A (en) 1985-10-01
EP0176333A3 (en) 1987-03-18
ZW16785A1 (en) 1987-04-15
ES8701737A1 (es) 1986-12-01
DK431185D0 (da) 1985-09-23
IL76467A0 (en) 1986-01-31
PL255499A1 (en) 1987-06-15
KR860002478A (ko) 1986-04-26
SU1409129A3 (ru) 1988-07-07

Similar Documents

Publication Publication Date Title
DE3583455D1 (de) Salbenbase.
DE3581430D1 (de) Detergens.
FI852587L (fi) Doerrkonstruktion.
DE3576268D1 (de) Hoergeraet.
DE3585265D1 (de) Fibronektinpraeparate.
DE3587525T2 (de) Stepmotor.
DE3581707D1 (de) Neigungsmesser.
DE3583080D1 (de) Mikrorechner.
FI77959B (fi) Hushaolls- eller motsvarande koeksanordning.
DE3582060D1 (de) Homopropargylamine.
DE3578421D1 (de) Glycidyloxydiketone.
FI73926B (fi) Standardhastighetsregulator foer motorfordon.
FI853639A0 (fi) Substituerade kinazolindioner.
DE3577708D1 (de) Diphenylhexafluorpropanabkoemmlinge.
DE3584628D1 (de) Xenocoumacine.
DE3586085D1 (de) Antitumor-4-hydroxy-2-zyklopentenonen.
FI80907B (fi) Kraftunderstoedd hudappliseringsapparat.
DE3579862D1 (de) Mikrorechner.
FI841797A0 (fi) Luftfuktare.
FI863749A (fi) Substituerade oxatiolaner.
DE3574867D1 (de) Aminokarnitine.
DE3587711D1 (de) Minaktivin.
NO156504C (no) Gasshvirveldanner.
FI844765A0 (fi) Skivfilter.
FI83368B (fi) Handelvapen.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ORTHO PHARMACEUTICAL CORPORATION